Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    J Mol Neurosci. 2004;23(3):157-65.

    APOE genotype effects on Alzheimer's disease onset and epidemiology.

    Source

    Stanford/VA Alzheimer Center, Palo Alto, CA 94304-1207, USA. ashford@stanford.edu

    Abstract

    The risk of developing Alzheimer's disease (AD) is tied most closely to age and appears to follow Gompertzian kinetics. However, specific genetic factors are also linked closely to AD, and the apolipoprotein E (APOE) genotype accounts for as much of 50% of the attributable risk for AD in many populations. This paper reviews the onset, diagnosis, and epidemiology of AD, specifically with regard to the APOE genotype and the interaction of the genotype with age.

    Copyright 2004 Humana Press Inc.

    PMID:
    15181244
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Springer

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk